Log in
Enquire now
DecImmune Therapeutics

DecImmune Therapeutics

A biotechnology company developing peptides and antibodies for inflammation and autoimmunity

OverviewStructured DataIssuesContributors

Contents

decimmune.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biopharmaceutical
Biopharmaceutical
Biology
Biology
Biotechnology
Biotechnology
Autoimmune disease
Autoimmune disease
Technology
Technology
Location
Boston
Boston
Cambridge, Massachusetts
Cambridge, Massachusetts
B2X
B2B
B2B
0
Founder
‌
Francis Moore
0
‌
Michael Carroll
0
AngelList URL
angel.co/decimmune-...herapeutics
Pitchbook URL
pitchbook.com/profiles.../51032-08
Email Address
contact@decimmune.com0
Investors
Astellas Venture Management
Astellas Venture Management
Broadview Ventures
Broadview Ventures
Amgen Ventures
Amgen Ventures
HealthCare Ventures
HealthCare Ventures
DUNS Number
611658860
Total Funding Amount (USD)
5,450,000
Latest Funding Round Date
February 26, 2013
Patents Assigned (Count)
4
Wellfound ID
decimmune-therapeutics
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like DecImmune Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.